Anti-influenza virus activity of the elenolic acid rich olive leaf ( L.) extract Isenolic

Seasonal flu is caused by influenza infection, a virus that spreads easily in human population with periodical epidemic outbreaks. The high mutational rate of influenza viruses leads to the emergence of strains resistant to the current treatments. Due to that, scientific research is focusing on the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Aurora Salamanca, Paula Almodóvar, Irene Jarama, Daniel González-Hedström, Marin Prodanov, Antonio Manuel Inarejos-García
Formato: article
Lenguaje:EN
Publicado: SAGE Publishing 2021
Materias:
Acceso en línea:https://doaj.org/article/6f5ea850efeb4451a2bb4c23a6c8df9e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6f5ea850efeb4451a2bb4c23a6c8df9e
record_format dspace
spelling oai:doaj.org-article:6f5ea850efeb4451a2bb4c23a6c8df9e2021-12-01T00:06:36ZAnti-influenza virus activity of the elenolic acid rich olive leaf ( L.) extract Isenolic2040-206610.1177/20402066211063391https://doaj.org/article/6f5ea850efeb4451a2bb4c23a6c8df9e2021-11-01T00:00:00Zhttps://doi.org/10.1177/20402066211063391https://doaj.org/toc/2040-2066Seasonal flu is caused by influenza infection, a virus that spreads easily in human population with periodical epidemic outbreaks. The high mutational rate of influenza viruses leads to the emergence of strains resistant to the current treatments. Due to that, scientific research is focusing on the development of new anti-influenza agents as alternative or complementary treatments. Olive tree ( Olea europaea L.) has been a source of ancestral remedies due to its antimicrobial activity. Thus, the aim of this study was to test the anti-influenza activity of a standardized olive leaf extract rich in elenolic acid (EA), Isenolic ® , compared with oseltamivir. Isenolic ® extract was characterized by High Performance Liquid Chromatography (HPLC)-Mass Spectrometry and its content in EA was determined by HPLC. Cytotoxicity, viral neuraminidase inhibitor activity and cell viability protection against influenza infection of Isenolic ® were tested in vitro using sialic acid overexpressing Madin-Darby Canine Kidney cells. Isenolic ® formulations showed a 4% and 8% dry basis. Oseltamivir and Isenolic ® extracts showed anti-influenza activity. The 8% Isenolic ® formulation showed a dose-dependent neuraminidase inhibitor activity higher than the 4% formulation, and preserved cell viability under viral infection. Thus, Isenolic ® become a promising natural alternative to existing influenza treatments.Aurora SalamancaPaula AlmodóvarIrene JaramaDaniel González-HedströmMarin ProdanovAntonio Manuel Inarejos-GarcíaSAGE PublishingarticleInfectious and parasitic diseasesRC109-216ENAntiviral Chemistry & Chemotherapy, Vol 29 (2021)
institution DOAJ
collection DOAJ
language EN
topic Infectious and parasitic diseases
RC109-216
spellingShingle Infectious and parasitic diseases
RC109-216
Aurora Salamanca
Paula Almodóvar
Irene Jarama
Daniel González-Hedström
Marin Prodanov
Antonio Manuel Inarejos-García
Anti-influenza virus activity of the elenolic acid rich olive leaf ( L.) extract Isenolic
description Seasonal flu is caused by influenza infection, a virus that spreads easily in human population with periodical epidemic outbreaks. The high mutational rate of influenza viruses leads to the emergence of strains resistant to the current treatments. Due to that, scientific research is focusing on the development of new anti-influenza agents as alternative or complementary treatments. Olive tree ( Olea europaea L.) has been a source of ancestral remedies due to its antimicrobial activity. Thus, the aim of this study was to test the anti-influenza activity of a standardized olive leaf extract rich in elenolic acid (EA), Isenolic ® , compared with oseltamivir. Isenolic ® extract was characterized by High Performance Liquid Chromatography (HPLC)-Mass Spectrometry and its content in EA was determined by HPLC. Cytotoxicity, viral neuraminidase inhibitor activity and cell viability protection against influenza infection of Isenolic ® were tested in vitro using sialic acid overexpressing Madin-Darby Canine Kidney cells. Isenolic ® formulations showed a 4% and 8% dry basis. Oseltamivir and Isenolic ® extracts showed anti-influenza activity. The 8% Isenolic ® formulation showed a dose-dependent neuraminidase inhibitor activity higher than the 4% formulation, and preserved cell viability under viral infection. Thus, Isenolic ® become a promising natural alternative to existing influenza treatments.
format article
author Aurora Salamanca
Paula Almodóvar
Irene Jarama
Daniel González-Hedström
Marin Prodanov
Antonio Manuel Inarejos-García
author_facet Aurora Salamanca
Paula Almodóvar
Irene Jarama
Daniel González-Hedström
Marin Prodanov
Antonio Manuel Inarejos-García
author_sort Aurora Salamanca
title Anti-influenza virus activity of the elenolic acid rich olive leaf ( L.) extract Isenolic
title_short Anti-influenza virus activity of the elenolic acid rich olive leaf ( L.) extract Isenolic
title_full Anti-influenza virus activity of the elenolic acid rich olive leaf ( L.) extract Isenolic
title_fullStr Anti-influenza virus activity of the elenolic acid rich olive leaf ( L.) extract Isenolic
title_full_unstemmed Anti-influenza virus activity of the elenolic acid rich olive leaf ( L.) extract Isenolic
title_sort anti-influenza virus activity of the elenolic acid rich olive leaf ( l.) extract isenolic
publisher SAGE Publishing
publishDate 2021
url https://doaj.org/article/6f5ea850efeb4451a2bb4c23a6c8df9e
work_keys_str_mv AT aurorasalamanca antiinfluenzavirusactivityoftheelenolicacidricholiveleaflextractisenolic
AT paulaalmodovar antiinfluenzavirusactivityoftheelenolicacidricholiveleaflextractisenolic
AT irenejarama antiinfluenzavirusactivityoftheelenolicacidricholiveleaflextractisenolic
AT danielgonzalezhedstrom antiinfluenzavirusactivityoftheelenolicacidricholiveleaflextractisenolic
AT marinprodanov antiinfluenzavirusactivityoftheelenolicacidricholiveleaflextractisenolic
AT antoniomanuelinarejosgarcia antiinfluenzavirusactivityoftheelenolicacidricholiveleaflextractisenolic
_version_ 1718406146694316032